学术探索
学术期刊
新闻热点
数据分析
智能评审

CLINICAL PHARMACOKINETICS OF DOXORUBICIN

被引：355
作者：
SPETH, PAJ
VANHOESEL, QGCM
HAANEN, C
机构：
[1] UNIV HOSP NIJMEGAN, DEPT MED ONCOL, NIJMEGAN, NETHERLANDS
[2] UNIV HOSP NIJMEGAN, DEPT HEMATOL, NIJMEGAN, NETHERLANDS
来源：
CLINICAL PHARMACOKINETICS | 1988年 / 15卷 / 01期
关键词：
D O I：
10.2165/00003088-198815010-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：15 / 31
页数：17
相关论文
共 157 条
[31]  
CHLEBOWSKI RT, 1984, CANCER TREAT REP, V68, P487
[32]  
CREAGAN ET, 1988, CANCER-AM CANCER SOC, V61, P19, DOI 10.1002/1097-0142(19880101)61:1<19::AID-CNCR2820610105>3.0.CO
[33]  
2-8
[34]   PHARMACOKINETICS OF ANTICANCER DRUGS IN CHILDREN [J].
CROM, WR ;
GLYNNBARNHART, AM ;
RODMAN, JH ;
TERESI, ME ;
KAVANAGH, RE ;
CHRISTENSEN, ML ;
RELLING, MV ;
EVANS, WE .
CLINICAL PHARMACOKINETICS, 1987, 12 (03) :168-213
[35]   STUDIES ON THE INVIVO DISPOSITION OF ADRIAMYCIN IN HUMAN-TUMORS WHICH EXHIBIT DIFFERENT RESPONSES TO THE DRUG [J].
CUMMINGS, J ;
MCARDLE, CS .
BRITISH JOURNAL OF CANCER, 1986, 53 (06) :835-838
[36]   INFLUENCE OF POLYSORBATE-80 (TWEEN-80) AND ETOPOSIDE (VP-16-213) ON THE PHARMACOKINETICS AND URINARY-EXCRETION OF ADRIAMYCIN AND ITS METABOLITES IN CANCER-PATIENTS [J].
CUMMINGS, J ;
FORREST, GJ ;
CUNNINGHAM, D ;
GILCHRIST, NL ;
SOUKOP, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (01) :80-84
[37]  
DESSYPYRIS EN, 1984, P AM ASS CANCER RES, V25
[38]  
DIFRONZO G, 1973, BIOMEDICINE, V19, P169
[39]  
DIMARCO A, 1964, CANCER CHEMOTH REP, P31
[40]  
DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33
12345678910